ATE26216T1 - Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung. - Google Patents

Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung.

Info

Publication number
ATE26216T1
ATE26216T1 AT83306702T AT83306702T ATE26216T1 AT E26216 T1 ATE26216 T1 AT E26216T1 AT 83306702 T AT83306702 T AT 83306702T AT 83306702 T AT83306702 T AT 83306702T AT E26216 T1 ATE26216 T1 AT E26216T1
Authority
AT
Austria
Prior art keywords
compositions containing
therapeutic use
containing interferon
interferon
hyroxymethyl
Prior art date
Application number
AT83306702T
Other languages
English (en)
Inventor
Kendall O Smith
Original Assignee
Ens Bio Logicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ens Bio Logicals Inc filed Critical Ens Bio Logicals Inc
Application granted granted Critical
Publication of ATE26216T1 publication Critical patent/ATE26216T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT83306702T 1982-11-04 1983-11-03 Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung. ATE26216T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/439,121 US4462986A (en) 1982-11-04 1982-11-04 Synergistic anti-herpes compositions
EP83306702A EP0109234B1 (de) 1982-11-04 1983-11-03 Zusammensetzungen mit Gehalt an Interferon und ihre therapeutische Anwendung

Publications (1)

Publication Number Publication Date
ATE26216T1 true ATE26216T1 (de) 1987-04-15

Family

ID=23743382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83306702T ATE26216T1 (de) 1982-11-04 1983-11-03 Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung.

Country Status (10)

Country Link
US (1) US4462986A (de)
EP (1) EP0109234B1 (de)
JP (1) JPS59130223A (de)
AT (1) ATE26216T1 (de)
AU (1) AU557894B2 (de)
CA (1) CA1239093A (de)
DE (1) DE3370587D1 (de)
HK (1) HK77989A (de)
MC (1) MC1552A1 (de)
ZA (1) ZA838179B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4857316A (en) * 1984-10-03 1989-08-15 Syntex (U.S.A.) Inc. Synergistic antiviral composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
JP2525104B2 (ja) * 1992-03-24 1996-08-14 日本碍子株式会社 樹脂含浸紙コンデンサコアおよびその製造方法
US5550114A (en) 1993-04-02 1996-08-27 Thomas Jefferson University Epidermal growth factor inhibitor
FI973784L (fi) * 1997-09-25 1999-03-26 Huhtamaeki Oy Ksylitolikaramelli, erityisesti kovakaramelli
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
IL161022A0 (en) * 2001-10-05 2004-08-31 Intermune Inc Methods of treating liver fibrosis and hepatitis c virus infection
EP1674104A1 (de) * 2004-12-24 2006-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Uridinderivaten als antivirale Agentien gegen Flavividae, insbesonders HCV
EP1991679A2 (de) * 2006-03-08 2008-11-19 Biomethodes Varianten des humanen interferon-gamma (ifngamma)
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2134292A1 (en) * 1971-04-30 1972-12-08 Inst Nat Sante Rech Med Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
PL247394A1 (en) * 1981-08-11 1984-10-22 Wellcome Found Process for preparing derivatives of purine
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
EP0080032A3 (de) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
WO1983002723A1 (en) * 1982-02-12 1983-08-18 Smith, Kendall, O. Anti-viral compositions

Also Published As

Publication number Publication date
AU557894B2 (en) 1987-01-15
AU2068183A (en) 1984-05-10
DE3370587D1 (en) 1987-05-07
MC1552A1 (fr) 1984-08-31
HK77989A (en) 1989-10-06
CA1239093A (en) 1988-07-12
ZA838179B (en) 1985-03-27
JPS59130223A (ja) 1984-07-26
US4462986A (en) 1984-07-31
EP0109234B1 (de) 1987-04-01
EP0109234A1 (de) 1984-05-23

Similar Documents

Publication Publication Date Title
ATE26216T1 (de) Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung.
FI943805A7 (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoito on
AU623512B2 (en) Phenyl pyrimidone derivatives, processes for their preparation, and their use therapeutic agents
FI832382A7 (fi) Fenyylialfa- asyylioksiasetamidijohdannaiset ja niiden terapeuttinen käyttö.
ATE66808T1 (de) Zellstimulierendes mittel.
ZA864873B (en) Heterocyclic substituted-phenoxyalkyl-isoxazoles and-furans,their preparation and use as antiviral agents
FI863971A7 (fi) Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa.
AU1795383A (en) Pharmaceutical preparations having analgetic and cytostatic activity
GB8914060D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
FI914611A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
EP0177940A3 (en) Hydrazine derivatives and their use
GB8914061D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GR3030150T3 (en) Use of Human Interferon-Beta 2A for the preparation of medicaments
EP0295695A3 (en) New pyrazoline derivatives and agents for treating cerebnew pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredrovascular diseases containing the same as active ingredient ient
DE3362327D1 (en) (1-arylcyclobutyl) alkylamine derivatives, their preparation and their use as therapeutic agents
GB8914062D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
FI821035A7 (fi) Imidatso/1,2-a/pyrimidiinijohdannaiset, niiden valmistus ja käyttö tautien hoidossa.
IT1188185B (it) 2-piridilcarbossammide particolarmente per uso farmaceutico
IT9041598A0 (it) Nuovo uso terapeutico del dipiridamolo
FI895286A7 (fi) Fenyylioksipropanoliamineja, niiden valmistus ja terapeuttinen käyttö
FI950533L (fi) Seco-nukleosidien liponulkeotidit, niiden valmistaminen sekä niiden käyttö virusten vastaisina lääkkeinä
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
IT1168854B (it) Derivati di carbapenem dotati di attivita' antibiotica e procedimento per la loro preparazione
MY112888A (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee